Generated by Llama 3.3-70B| Cell Press | |
|---|---|
| Name | Cell Press |
| Founder | Benedict Gross |
| Country | United States |
| Distribution | Elsevier |
Cell Press is a leading international publisher of scientific journals, founded by Benedict Gross and Janet Rossi, and is part of the Elsevier group, which also includes Pergamon Press and Academic Press. Cell Press publishes a range of high-impact journals, including Cell, Neuron, and Immunity, which are highly regarded in the scientific community, with many Nobel Prize winners, such as James Watson, Francis Crick, and Rosalind Franklin, having published their research in these journals. The company is headquartered in Cambridge, Massachusetts, and has close ties with institutions such as Harvard University, Massachusetts Institute of Technology, and Stanford University. Cell Press also collaborates with other prominent publishers, including Nature Publishing Group and Wiley-Blackwell.
The history of Cell Press dates back to the 1970s, when Benedict Gross and Janet Rossi founded the company with the goal of creating a high-quality scientific journal that would publish cutting-edge research in the field of cell biology. The first issue of Cell was published in 1974, and it quickly gained a reputation as a leading journal in the field, with contributions from prominent scientists such as David Baltimore, Renato Dulbecco, and Howard Temin. Over the years, Cell Press has expanded its portfolio to include other journals, such as Neuron, Immunity, and Cancer Cell, which have become highly respected in their respective fields, with many Lasker Award winners, such as Michael Bishop and Harold Varmus, having published their research in these journals. Cell Press has also established partnerships with other prominent scientific organizations, including the American Association for the Advancement of Science, The National Academy of Sciences, and the European Molecular Biology Organization.
Cell Press publishes a range of scientific journals, including Cell, Neuron, Immunity, Cancer Cell, and Molecular Cell, which cover a broad range of topics in the life sciences, from molecular biology to neuroscience and cancer research. The company's journals are highly regarded for their high-impact research, with many Breakthrough Prize winners, such as Jennifer Doudna and Emmanuelle Charpentier, having published their research in these journals. Cell Press also publishes a number of review journals, including Trends in Biochemical Sciences and Trends in Cell Biology, which provide comprehensive overviews of the latest research in specific fields, with contributions from prominent scientists such as Eric Kandel and Huda Zoghbi. The company's journals are widely read and cited, with many National Medal of Science winners, such as Rita Levi-Montalcini and Stanley Prusiner, having published their research in these journals.
Cell Press has had a significant impact on the scientific community, with many of its journals being considered among the most influential in their respective fields, with high impact factors, according to Journal Citation Reports. The company's journals have published many groundbreaking papers, including those by James Allison and Tasuku Honjo, who were awarded the Nobel Prize in Physiology or Medicine in 2018 for their discovery of cancer immunotherapy. Cell Press has also been recognized for its commitment to scientific excellence, with many of its journals being awarded National Academy of Sciences prizes, such as the NAS Award in Molecular Biology, and Albert Lasker Awards, such as the Lasker Award for Basic Medical Research. The company has also established partnerships with other prominent scientific organizations, including the Howard Hughes Medical Institute, The Wellcome Trust, and the Bill and Melinda Gates Foundation.
Cell Press has an open access policy, which allows authors to make their research available to the public, free of charge, through PubMed Central and other online repositories, in accordance with the National Institutes of Health's Public Access Policy. The company also offers a range of open access options, including gold open access and green open access, which allow authors to choose how they want to make their research available, with support from organizations such as the Open Access Scholarly Publishers Association and the Directory of Open Access Journals. Cell Press has also partnered with other prominent publishers, including PLOS and BioMed Central, to promote open access and increase the visibility of scientific research, with the goal of advancing scientific knowledge and promoting public health, in collaboration with institutions such as the World Health Organization and the National Library of Medicine.
Some of the most notable journals published by Cell Press include Cell, Neuron, Immunity, Cancer Cell, and Molecular Cell, which are all highly regarded in their respective fields, with many Wolf Prize winners, such as David Julius and Linda Buck, having published their research in these journals. Other notable journals include Developmental Cell, Cell Metabolism, and Cell Stem Cell, which cover a range of topics in developmental biology, metabolism, and stem cell biology, with contributions from prominent scientists such as Eric Wieschaus and Christianne Nusslein-Volhard. These journals have published many groundbreaking papers, including those by Andrew Fire and Craig Mello, who were awarded the Nobel Prize in Physiology or Medicine in 2006 for their discovery of RNA interference, and have been recognized for their high impact and influence in the scientific community, with support from organizations such as the American Cancer Society and the March of Dimes. Category:Scientific publishing companies